Covestor LTD Pliant Therapeutics, Inc. Transaction History

Covestor LTD

  • $160 Million
  • Q3 2024

A detailed history of Covestor LTD transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Covestor LTD holds 5 shares of PLRX stock, worth $61. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 6 16.67%
Holding current value
$61
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$10.52 - $14.35 $10 - $14
-1 Reduced 16.67%
5 $0
Q4 2023

Feb 09, 2024
SELL
$12.85 - $19.15 $12 - $19
-1 Reduced 14.29%
6 $0
Q3 2023

Nov 13, 2023
BUY
$14.58 - $20.15 $102 - $141
7 New
7 $0
Q1 2022

May 13, 2022
SELL
$7.01 - $14.1 $0 - $0
0 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$12.27 - $18.26 $0 - $0
0 New
0 $0

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email